赛诺菲和Sobi公司延长了与世界血友病联合会人道主义援助计划的合作伙伴关系-动脉网

Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program

CISION 等信源发布 2025-04-25 12:01



可切换为仅中文







Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance

最长五年的合同延期，以药品捐赠和财务援助支持WFH人道主义援助计划

MONTREAL

蒙特利尔

，

April 25, 2025

2025年4月25日

/PRNewswire/ -- The World Federation of Hemophilia (WFH) and WFH

/PRNewswire/ -- 世界血友病联合会 (WFH) 和 WFH

USA

美国

, together with Sanofi, through its philanthropic organization Foundation S, and Sobi, announce the signing of a contract providing support to the WFH Humanitarian Aid Program in the form of medicine donations and financial assistance for up to 5 years. This is the second renewal of the collaboration, which has been in place for more than ten years and demonstrates the partners' commitment to providing the necessary care and resources for people with hemophilia around the world..

，连同赛诺菲及其慈善组织Foundation S和Sobi一道，宣布签署了一份合同，为WFH人道主义援助计划提供支持，以药物捐赠和财务援助的形式，为期长达5年。这是该合作的第二次续约，这项合作已经持续了十多年，展示了合作伙伴们对为全球血友病患者提供必要护理和资源的承诺。

继续阅读

Picture of the WFH, WFH USA, Sanofi and Sobi representatives during the Comprehensive Care Summit, in Dubai. (CNW Group/World Federation of Hemophilia)

在迪拜举行的综合护理峰会期间，WFH、WFH美国、赛诺菲和Sobi代表的合影。（CNW集团/世界血友病联盟）

The commitment includes the donation of up to 100 million international units (IU) of factor therapy per year that will be distributed by the WFH Humanitarian Aid Program worldwide to developing countries. This will enable the WFH to deliver aid to people with inherited bleeding disorders across the globe..

该承诺包括每年捐赠多达1亿国际单位 (IU) 的凝血因子治疗剂，这些治疗剂将通过WFH人道主义援助计划在全球范围内分发给发展中国家。这将使WFH能够向全球患有遗传性出血疾病的患者提供援助。

The new signing comes as Sanofi and Sobi celebrate the tenth anniversary of answering the WFH call to action to support the global inherited bleeding disorders community through the donation of treatment products and financial aid. Between 2014 and 2024, Sanofi and Sobi provided one billion IUs of treatment product, enabling the treatment of 22,219 people with inherited bleeding disorders..

新签署的协议正值赛诺菲和Sobi庆祝响应WFH行动呼吁十周年之际，该行动旨在通过捐赠治疗产品和提供经济援助来支持全球遗传性出血性疾病社区。在2014年至2024年期间，赛诺菲和Sobi提供了10亿国际单位的治疗产品，使22,219名遗传性出血性疾病患者得到治疗。

Alaa Hamed

阿拉·哈米德

Global Head of Medical Affairs, Rare Diseases, Sanofi

全球医学事务主管，罕见病，赛诺菲

'Building on the legacy of the original ten-year, one billion IU commitment, this new agreement reaffirms Sanofi and Sobi's dedication to creating a predictable, sustainable program that addresses unmet needs and advances the standard of care for hemophilia worldwide. Over the past decade, these contributions have expanded treatment availability and transformed patient outcomes. We are proud to leverage the Foundation S expertise and continue providing essential treatments and with this renewal ensuring improvement to the quality of life for thousands of individuals in developing countries for years to come.'.

“在原有十年十亿国际单位承诺的遗产基础上，这项新协议重申了赛诺菲和Sobi致力于创建一个可预测且可持续的项目，以满足未被满足的需求并推动全球血友病护理标准的进步。在过去的十年中，这些贡献扩大了治疗的可及性，并改变了患者的治疗结果。我们为能够利用基金会的专业知识继续提供关键治疗感到自豪，并通过此次续约确保未来多年发展中国家中成千上万的患者生活质量得到改善。”

Lydia Abad-Franch

莉迪亚·阿巴德-弗朗什

Head of R&D and Chief Medical Officer, Sobi

Sobi公司研发部主管兼首席医学官

'We are immensely proud to continue our contributions to the Humanitarian Aid Program of the World Federation of Hemophilia (WFH). Since the initial pledge, over 22,000 people with hemophilia have been treated with factor donated by Sobi and Sanofi. We are thrilled to continue our partnership with the WFH and look forward to the positive impact it will have on the lives of those affected by inherited bleeding disorders.' .

“我们非常自豪能够继续为世界血友病联合会（WFH）的人道主义援助计划做出贡献。自最初承诺以来，已有超过22,000名血友病患者接受了由Sobi和赛诺菲捐赠的凝血因子治疗。我们很高兴能继续与WFH合作，并期待它将对受遗传性出血疾病影响的人们生活产生的积极影响。”

Cesar Garrido

凯撒·加里多

President, World Federation of Hemophilia

世界血友病联合会主席

The contributions of Sanofi and Sobi to the WFH Humanitarian Aid Program can't be overstated — and especially in the last ten years after they answered the WFH call to action. This new five-year contract will continue that legacy of support for the global inherited bleeding disorders community, and it will help us get closer to our shared vision of Treatment for All.'.

赛诺菲和Sobi对世界联合基金会（WFH）人道主义援助计划的贡献怎么强调都不为过，尤其是在他们响应WFH行动号召后的过去十年中。这项新的五年合同将继续为全球遗传性出血疾病社区提供支持的传统，并有助于我们更接近“全民治疗”的共同愿景。

Mark Skinner

马克·斯金纳

Board Member, World Federation of Hemophilia,

世界血友病联合会董事会成员，

USA

美国

'The WFH Humanitarian Aid program is an extraordinary example of collaboration. The life-changing impact of this program is a testament to what can be achieved by working together with our industry partners. The visionary leadership of Sobi and Sanofi's Foundation S has provided inspiration for others in industry, hope for patients and their families, and elevated capacity of health care professionals around the world.'.

“WFH人道主义援助计划是合作的非凡典范。该计划改变生活的影响力证明了与行业伙伴共同努力所能取得的成果。Sobi和赛诺菲基金会S的富有远见的领导为行业中的其他人带来了启发，为患者及其家人带来了希望，并提升了全球医疗保健专业人员的能力。”

About the World Federation of Hemophilia

关于世界血友病联合会

The World Federation of Hemophilia (WFH) is a non-profit organization dedicated to improving and sustaining care for people with inherited bleeding disorders around the world. At the WFH, national member organizations (NMOs) and health care professionals (HCPs) work together to provide care for people with inherited bleeding disorders around the world.

世界血友病联合会（WFH）是一个非营利组织，致力于改善和持续为全球遗传性出血性疾病患者提供护理。在WFH，国家成员组织（NMO）和医疗保健专业人员（HCP）共同努力，为全球遗传性出血性疾病患者提供护理。

We partner with governments and hemophilia treatment centres to enhance knowledge through training and provide tools they need to identify, support and treat people living with bleeding disorders in their communities, while promoting global advocacy and collaboration to achieve our common goals. The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries.

我们与政府和血友病治疗中心合作，通过培训提高知识水平，并提供他们所需的工具，以识别、支持和治疗社区中患有出血性疾病的人，同时推动全球倡导和合作以实现我们的共同目标。WFH人道主义援助计划通过为发展中国家的遗传性出血性疾病患者提供急需的支持，改善了他们无法获得护理和治疗的状况。

By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda, our Contributor..

通过为患者提供更可预测和可持续的人道主义援助捐赠流动，WFH人道主义援助计划使患者能够持续和可靠地获得治疗和护理。如果没有赛诺菲和Sobi（我们的创始远见贡献者）、拜耳、CSL Behring和罗氏（我们的远见贡献者）、Grifols（我们的领导贡献者）以及武田（我们的贡献者）的慷慨支持，这一切都不可能实现。

Our vision of Treatment for All is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, or where they live. Our mission is to improve and sustain care for people with inherited bleeding disorders around the world.

我们的“全民治疗”愿景是，让所有遗传性出血性疾病患者无论出血类型、性别或居住地如何，都能获得治疗。我们的使命是改善并持续为全球遗传性出血性疾病患者提供护理。

To find out more about the WFH, please visit

要了解有关 WFH 的更多信息，请访问

www.wfh.org

。

About WFH

关于WFH

USA

美国

WFH

在家工作

USA

美国

furthers the mission of the WFH in the U.S. by deepening engagement of American citizens with our global vision of Treatment for All and raising funds to bring that vision to life. By working with the World Federation of Hemophilia, we help transform communities by equipping and empowering WFH national member organizations (NMOs) and healthcare providers with the knowledge and tools they need to identify, support and treat people living with bleeding disorders around the world.

通过深化美国公民对我们“全民治疗”的全球愿景的参与，并筹集资金以实现这一愿景，进一步推动了WFH在美国的使命。通过与世界血友病联盟合作，我们帮助转变社区，为WFH国家成员组织（NMO）和医疗保健提供者配备所需的知识和工具，以识别、支持和治疗全球患有出血性疾病的患者。

To find out more about WFH .

要了解更多关于WFH的信息。

USA

美国

, please visit

，请访问

wfh.org/usa

。

About Sanofi

关于赛诺菲

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions..

我们是一家创新的全球医疗保健公司，由一个目标驱动：我们追求科学的奇迹以改善人们的生活。我们的团队遍布全球，致力于通过努力将不可能变为可能来改变医学实践。我们为全球数百万人提供可能改变生活的治疗选择和拯救生命的疫苗保护，同时将可持续发展和社会责任置于我们雄心的核心。

Sanofi is listed on EURONEXT: SAN andNASDAQ:

赛诺菲在 EURONEXT：SAN 和 NASDAQ 上市：

SNY

索尼

About Foundation S – The Sanofi Collective

关于基金会S——赛诺菲集体

Foundation S strives to create healthier futures for generations to come. We are driven by a singular purpose: to improve the lives of vulnerable populations by catalyzing community–based solutions, expanding access to medicines, and mobilizing collective action.

基金会S致力于为子孙后代创造更健康的未来。我们秉持一个单一的目标：通过催化社区基础解决方案、扩大药品获取渠道和动员集体行动，改善弱势群体的生活。

About Sobi

关于Sobi

Sobi® is a global biopharma company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across

Sobi® 是一家全球生物制药公司，致力于改变罕见病和衰弱性疾病患者的生活。Sobi 在血液学、免疫学和专科护理领域提供可靠且创新的药物，拥有大约1800名员工。

Europe

欧洲

，

North America

北美

, the

，这个

Middle East

中东地区

，

Asia